ThinkEquity Partners

Analysts at ThinkEquity Partners upgrade Dollar General Corp (NYSE: DG) from "hold" to "buy." The target price for DG is set to $39. DG's shares lost 7.30% to close at $30.99 yesterday. More Analyst Ratings here

Analyst Glenn Garmont of ThinkEquity Partners maintains his "buy" rating on Omnicell, Inc (NASDAQ: OMCL). OMCL is set to announce its Q1 results on April 26 after the market closes. According to ThinkEquity Partners, the company will report “revenue/non-GAAP EPS of $53M/$0.09, both roughly in line...

Analyst Brian Skorney of ThinkEquity Partners maintains his "hold" rating on Vertex Pharmaceuticals (NASDAQ: VRTX). According to ThinkEquity Partners, “An accepted but unpublished article, now available online in the journal Hepatology, outlines the first study indicating that genetic variations in...

Analysts at ThinkEquity Partners reiterate their "buy" rating on Brocade Communications Systems Inc (NASDAQ: BRCD). The target price for BRCD is set to 5.57. “Given that close to half of the quarter remains, we believe it is not feasible to gauge the health of Brocade's business one way or the...

Analysts at ThinkEquity Partners reiterate their "buy" rating on Blue Coat Systems Inc (NASDAQ: BCSI), while raising their estimates for the company. The target price for BCSI is set to $31.64. ”We believe Blue Coat's strategic product focus is riding the tailwind of several industry trends (...

Analyst Rajesh Ghai of ThinkEquity Partners reiterates his "buy" rating on Netezza Corporation (NYSE: NZ). According to ThinkEquity Partners, recent checks within the System Integrator community are indicating rising demand for Data Warehousing Projects and a strong traction for TwinFin,...

Analyst Brian Skorney of ThinkEquity Partners maintains his "hold" rating on Idenix Pharmaceuticals (NASDAQ: IDIX). The key driver of Idenix Pharmaceuticals’ shares is the company's proprietary nucleotide analog polymerase inhibitor, IDX184. IDIX has reported top-line results from the ongoing 14-...

Analysts at ThinkEquity Partners maintain their "buy" rating on Blue Coat Systems Inc (NASDAQ: BCSI), while raising their estimates for the company. According to ThinkEquity Partners, Blue Coat Systems has reported its FQ3 EPS and revenues significantly ahead of the estimates and the consensus,...

Analysts at ThinkEquity Partners maintain their "buy" rating on Sourcefire Inc (NASDAQ: FIRE). According to ThinkEquity Partners, Sourcefire remains well-positioned to benefit from secular trends driving the Intrusion Detection and Prevention markets. “Our checks suggest increased government...

Analysts at ThinkEquity Partners upgrade The Knot Inc (NASDAQ: KNOT) from "hold" to "buy." Knot’s shares fell significantly following the Q4 earnings release due to a greater-than-expected negative impact from the Macy's (NYSE: M) renegotiation. “While the Macy's departure presents near-term...